IRIS
BORDI, Cesare
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.752
AS - Asia 2.070
EU - Europa 1.679
SA - Sud America 288
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
Totale 6.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.668
SG - Singapore 806
CN - Cina 755
IE - Irlanda 340
UA - Ucraina 287
SE - Svezia 276
FI - Finlandia 270
BR - Brasile 224
DE - Germania 193
HK - Hong Kong 155
VN - Vietnam 123
TR - Turchia 80
ZA - Sudafrica 76
NL - Olanda 73
GB - Regno Unito 71
CA - Canada 63
IN - India 63
IT - Italia 58
RU - Federazione Russa 39
AR - Argentina 27
BE - Belgio 22
BD - Bangladesh 17
EC - Ecuador 11
IQ - Iraq 11
MX - Messico 11
FR - Francia 10
ES - Italia 9
JP - Giappone 9
VE - Venezuela 9
KE - Kenya 7
PL - Polonia 7
PY - Paraguay 7
EU - Europa 6
LT - Lituania 6
PK - Pakistan 6
UZ - Uzbekistan 6
EG - Egitto 5
IR - Iran 5
JO - Giordania 5
MA - Marocco 5
DZ - Algeria 4
NP - Nepal 4
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LK - Sri Lanka 3
OM - Oman 3
AL - Albania 2
AO - Angola 2
AT - Austria 2
BG - Bulgaria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CO - Colombia 2
ET - Etiopia 2
GE - Georgia 2
ID - Indonesia 2
JM - Giamaica 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
UY - Uruguay 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GI - Gibilterra 1
IL - Israele 1
LB - Libano 1
MN - Mongolia 1
NG - Nigeria 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.903
Salva come PNG Salva come JPEG
Città #
Singapore 401
Chandler 375
Dublin 339
Jacksonville 316
Ashburn 288
Santa Clara 228
Beijing 204
Hong Kong 155
Dearborn 138
Boardman 119
Ann Arbor 116
Nanjing 84
Johannesburg 72
San Mateo 69
Princeton 68
Izmir 67
Los Angeles 64
Shanghai 61
Dallas 54
Pune 48
Wilmington 45
Toronto 43
Ho Chi Minh City 38
Munich 38
New York 35
Woodbridge 35
Helsinki 34
Kunming 33
Nanchang 30
Jinan 26
Hanoi 24
Shenyang 24
Brussels 22
Buffalo 21
Moscow 21
Parma 21
São Paulo 20
Hebei 19
Tianjin 19
Hefei 18
Jiaxing 16
Changsha 14
Guangzhou 14
Hangzhou 14
Turku 13
Auburn Hills 11
Bremen 10
Haikou 10
Des Moines 9
Redondo Beach 9
San Francisco 9
Tokyo 9
Brooklyn 8
Atlanta 7
Baghdad 7
Chengdu 7
Dhaka 7
Ottawa 7
Porto Alegre 7
Seattle 7
Sorocaba 7
Warsaw 7
Asunción 6
Biên Hòa 6
Council Bluffs 6
Haiphong 6
Lanzhou 6
London 6
Nairobi 6
Norwalk 6
Wenzhou 6
West Jordan 6
Zhengzhou 6
Amman 5
Ankara 5
Belo Horizonte 5
Colombo 5
Da Nang 5
Montreal 5
Ningbo 5
Tashkent 5
Borås 4
Cairo 4
Columbus 4
Curitiba 4
Denver 4
Frankfurt am Main 4
Fremont 4
Fuzhou 4
Guayaquil 4
Houston 4
Orem 4
Poplar 4
Rio Saliceto 4
Taizhou 4
Algiers 3
Andover 3
Baku 3
Baotou 3
Boston 3
Totale 4.218
Salva come PNG Salva come JPEG
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 160
Classification of gastric endocrine cells at the light and electron microscopical levels 144
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 142
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 140
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 140
Endocrine tumors of the gastrointestinal system 139
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. 137
AMPULLARY ADENOCARCINOMA IN VON RECKLINGHAUSEN’S DISEASE. CASE REPORT AND LITERATURE REVIEW. 135
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 134
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 133
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 131
Different patterns of 11q allelic losses in digestive endocrine tumors 127
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 126
Pleomorph poorly differentiated endocrine carcinoma of the rectum 125
È L’ANGIOGENESI UN FATTORE PROGNOSTICO NEGLI ADENOCARCINOMI DEL COLON-RETTO IN STADIO B DI DUKES? 125
Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding 123
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 122
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 121
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 121
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 120
Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome 119
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 119
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture 119
Classification of neuroendocrine tumours 118
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 118
Biclonality of gastric lymphomas 112
Criteria for malignancy in gastrointestinal endocrine tumors 111
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I 110
Aetiology, molecular pathogenesis and genetics 110
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 108
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 108
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 107
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. 105
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. 103
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 102
Poorly differentiated endocrine carcinoma 99
Multiple endocrine neoplasia type 1 99
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy 98
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases 98
Gastric neuroendocrine neoplasms: tumor clonality and malignancy associated large X-chromosomal deletions 96
Non-functioning tumours and microadenomas 91
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 91
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms 90
Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case 88
Pancreatic endocrine tumours: Introduction 87
Heterotopic mesenteric ossification (Intraabdominal myositis ossificans): Report of five cases 87
Highlights on biology of endocrine tumours of the gut and pancreas 85
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: Associations with clinicopathological and molecular features 84
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas 83
Mixed exocrine-endocrine carcinomas 82
Gastrinomas 80
PTU-064 Identification of Syne 1 and Foxe 1 Hypermethylation to improve diagnosis and amangement of colorectal neoplasia in Inflammatory Bowel disease 79
Multiple endocrine neoplasia (MEN)-associated tumours 77
Prognostic factors in gastrointestinal endocrine tumors 76
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection 73
Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool 73
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis 72
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma 71
Hypergastrinemia and gastric enterochromaffin-like cells 70
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 69
Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up 67
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 66
The normal endocrine cell of the gut. Changing concepts and new evidences 66
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 65
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. 64
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p 61
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets 59
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids 49
Totale 6.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 4 62 4 104 14 69 5
2021/2022367 11 2 2 26 13 7 48 64 17 31 46 100
2022/20231.269 147 135 55 107 114 141 16 73 428 4 37 12
2023/2024414 29 41 5 2 37 153 22 29 5 21 24 46
2024/20251.347 18 78 91 57 170 179 54 56 177 114 96 257
2025/20261.477 252 233 245 222 470 55 0 0 0 0 0 0
Totale 6.909